These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches. Lee HY; Chen YJ; Li CC; Li WM; Hsu YL; Yeh HC; Ke HL; Huang CN; Li CF; Wu WJ; Kuo PL Int J Med Sci; 2019; 16(1):93-105. PubMed ID: 30662333 [TBL] [Abstract][Full Text] [Related]
6. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma. Lu H; Liang Y; Guan B; Shi Y; Gong Y; Li J; Kong W; Liu J; Fang D; Liu L; He Q; Shakeel M; Li X; Zhou L; Ci W Theranostics; 2020; 10(10):4323-4333. PubMed ID: 32292497 [No Abstract] [Full Text] [Related]
7. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA Profiling in Patients with Upper Tract Urothelial Carcinoma Associated with Balkan Endemic Nephropathy. Popovska-Jankovic K; Noveski P; Jankovic-Velickovic L; Stojnev S; Cukuranovic R; Stefanovic V; Toncheva D; Staneva R; Polenakovic M; Plaseska-Karanfilska D Biomed Res Int; 2016; 2016():7450461. PubMed ID: 27218105 [TBL] [Abstract][Full Text] [Related]
9. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract. Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476 [TBL] [Abstract][Full Text] [Related]
10. Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study. Calandrella ML; Francesconi S; Caprera C; Mosillo C; Caserta C; Giannarelli D; Corsi M; Macrini S; Guida A; Ascani S; Bracarda S BMC Cancer; 2022 Feb; 22(1):168. PubMed ID: 35164713 [TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact? Colin P; Seisen T; Mathieu R; Shariat SF; Rouprêt M Transl Androl Urol; 2016 Oct; 5(5):648-654. PubMed ID: 27785421 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461 [TBL] [Abstract][Full Text] [Related]
13. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma. Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758 [TBL] [Abstract][Full Text] [Related]
14. Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy. Cimadamore A; Scarpelli M; Santoni M; Cheng L; Lopez-Beltran A; Montironi R Expert Rev Mol Diagn; 2018 Dec; 18(12):1021-1028. PubMed ID: 30452305 [TBL] [Abstract][Full Text] [Related]
15. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy. Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522 [TBL] [Abstract][Full Text] [Related]
16. [Molecular changes in development and progression of urothelial carcinoma]. Hartmann A Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910 [TBL] [Abstract][Full Text] [Related]
17. Expression status of GATA3 and mismatch repair proteins in upper tract urothelial carcinoma. Wang Y; Zhang J; Wang Y; Wang S; Zhang Y; Miao Q; Gao F; He H Front Med; 2019 Dec; 13(6):730-740. PubMed ID: 31020542 [TBL] [Abstract][Full Text] [Related]
19. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M; BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159 [TBL] [Abstract][Full Text] [Related]
20. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]